CR11448A - Moduladores de y-secretasa con elances de carbono - Google Patents

Moduladores de y-secretasa con elances de carbono

Info

Publication number
CR11448A
CR11448A CR11448A CR11448A CR11448A CR 11448 A CR11448 A CR 11448A CR 11448 A CR11448 A CR 11448A CR 11448 A CR11448 A CR 11448A CR 11448 A CR11448 A CR 11448A
Authority
CR
Costa Rica
Prior art keywords
elances
carbon
secretase modulators
secretase
modulators
Prior art date
Application number
CR11448A
Other languages
English (en)
Inventor
Yung Ho Chin
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CR11448A publication Critical patent/CR11448A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con los compuestos de la formula (I) como se describe en la presente, en donde las definiciones de A, X, R1, R2, R3, R4, R5, R6, R7, Y R8 se proporcionan en la descripción.
CR11448A 2007-10-19 2010-05-19 Moduladores de y-secretasa con elances de carbono CR11448A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98120907P 2007-10-19 2007-10-19

Publications (1)

Publication Number Publication Date
CR11448A true CR11448A (es) 2011-01-14

Family

ID=40338749

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11448A CR11448A (es) 2007-10-19 2010-05-19 Moduladores de y-secretasa con elances de carbono

Country Status (17)

Country Link
US (1) US8692017B2 (es)
EP (1) EP2215043B1 (es)
JP (1) JP5417334B2 (es)
KR (1) KR101618068B1 (es)
CN (1) CN101896452B (es)
AU (1) AU2008312355B2 (es)
BR (1) BRPI0818773A2 (es)
CA (1) CA2702959C (es)
CO (1) CO6280527A2 (es)
CR (1) CR11448A (es)
EA (1) EA019710B1 (es)
ES (1) ES2401833T3 (es)
IL (1) IL205046A (es)
MX (1) MX2010004310A (es)
NI (1) NI201000065A (es)
WO (1) WO2009052334A1 (es)
ZA (1) ZA201003520B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006041830A2 (en) * 2004-10-07 2006-04-20 Merck & Co., Inc. Cgrp receptor antagonists
BRPI0817433A2 (pt) 2007-10-19 2015-06-16 Janssen Pharmaceutica Nv Moduladores de gama-secretase piperidinila e piperazinila
AU2008312355B2 (en) 2007-10-19 2013-07-04 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
EA018862B1 (ru) 2007-10-19 2013-11-29 Янссен Фармацевтика, Н.В. МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ
CN105801350B (zh) * 2016-04-29 2018-07-27 宜春学院 二芳基甲醇类化合物的合成方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790287A (fr) 1971-10-28 1973-04-19 Delalande Sa Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique
BE826017R (fr) 1974-03-19 1975-08-26 Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique
US4252951A (en) * 1979-10-09 1981-02-24 Eli Lilly And Company Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid
US5391817A (en) * 1993-12-21 1995-02-21 Bristol-Myers Squibb Biaryl phospholipase A2 inhibitors
US5877399A (en) 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
AU5702201A (en) 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
DE10131899A1 (de) 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
BRPI0411582A (pt) * 2003-06-16 2006-08-08 Anacor Pharmaceuticals Inc substáncias terapêuticas contendo boro hidroliticamente resistentes e método de uso
WO2006004555A1 (en) 2004-06-30 2006-01-12 Paysetter Pte Ltd System and method for facilitating transfer of physical money and/or credit
DE102004033876B4 (de) 2004-07-13 2009-01-15 Christoph Kaesbohrer Dreidimensionales Struktursystem
GB0416508D0 (en) 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
EP1650183A1 (en) 2004-10-21 2006-04-26 Cellzome Ag (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy
EP1849762B1 (en) 2006-04-21 2009-07-15 Cellzome Limited Substituted biphenyl carboxylic acids and derivatives thereof
PL1847524T3 (pl) 2006-04-21 2010-03-31 Cellzome Ltd Pochodne terfenylu do leczenia choroby Alzheimera
EA200802415A1 (ru) * 2006-06-09 2009-06-30 Икос Корпорейшн Замещенные фенилуксусные кислоты в качестве dp-2-антагонистов
WO2007146838A2 (en) 2006-06-09 2007-12-21 Icos Corporation Substituted phenyl acetic acids as dp-2 antagonists
AU2008312771B2 (en) 2007-10-17 2012-11-01 Janssen Pharmaceutica, N.V. Biphenyl carboxylic acids and derivatives thereof
AU2008312355B2 (en) 2007-10-19 2013-07-04 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
BRPI0817433A2 (pt) 2007-10-19 2015-06-16 Janssen Pharmaceutica Nv Moduladores de gama-secretase piperidinila e piperazinila
EA018862B1 (ru) 2007-10-19 2013-11-29 Янссен Фармацевтика, Н.В. МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ
BRPI0817425A2 (pt) 2007-10-19 2015-06-16 Janssen Pharmaceutica Nv Moduladores de gama-secretase ligados à amida
CN101903334A (zh) 2007-10-19 2010-12-01 詹森药业有限公司 Gsm中间体
US7968725B2 (en) 2008-07-22 2011-06-28 Janssen Pharmaceutica N.V. Pyridinyl modulators of γ-secretase

Also Published As

Publication number Publication date
IL205046A (en) 2014-09-30
EA019710B1 (ru) 2014-05-30
KR101618068B1 (ko) 2016-05-04
JP5417334B2 (ja) 2014-02-12
JP2011500719A (ja) 2011-01-06
BRPI0818773A2 (pt) 2015-04-14
EA201070496A1 (ru) 2010-10-29
ZA201003520B (en) 2012-07-25
US8692017B2 (en) 2014-04-08
NI201000065A (es) 2010-09-13
CA2702959C (en) 2016-07-26
WO2009052334A1 (en) 2009-04-23
EP2215043A1 (en) 2010-08-11
AU2008312355B2 (en) 2013-07-04
MX2010004310A (es) 2010-05-03
CO6280527A2 (es) 2011-05-20
CN101896452A (zh) 2010-11-24
IL205046A0 (en) 2010-11-30
ES2401833T3 (es) 2013-04-24
CN101896452B (zh) 2013-07-31
KR20100090688A (ko) 2010-08-16
CA2702959A1 (en) 2009-04-23
AU2008312355A1 (en) 2009-04-23
US20090105288A1 (en) 2009-04-23
EP2215043B1 (en) 2013-03-06

Similar Documents

Publication Publication Date Title
MX2014002770A (es) Nuevos derivados dihidroquinolina-2-ona.
HN2011000076A (es) Derivados de piridino-piridinonas, su preparacion.
ECSP109921A (es) Sulfonamidas como moduladores de trpm8
CR20110520A (es) Acetamidas sustituidas por n-(hetero)-arilo y 2-(hetero)-arilo para usarse como moduladoras de la señalización de wnt
ES2531324T3 (es) Intermedio para producir un derivado de gamma-aminoácido bicíclico
UY31148A1 (es) Compuestos de piperazina con accion herbicida (ii)
UY30881A1 (es) Derivados de fenotiazina, procedimientos y su uso como productos farmacéuticos
ECSP10010206A (es) Inhibidores de la replicación del virus de la imunodeficiencia humana
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
PA8649401A1 (es) Analogos de anilino-pirimidina
UY31183A1 (es) Derivados de pirazinona y procesos para su preparación
EA201000950A1 (ru) Азолилметилоксираны, их применение, а также содержащие их средства
CO6491082A2 (es) Derivados de n 1-sulfonil-5-fluoropirimidinona
BR112012033350A2 (pt) &#34;composição e métodos para modular a via de sinalização de wnt&#34;
UY31538A1 (es) Inhibidores de la polimerasa virica
MX2012008141A (es) Compuestos y metodos.
UY31152A1 (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
ECSP12011651A (es) Derivados de 5-fluoro-2-oxopirimidina-1(2h)-carboxilato
BR112015007422A2 (pt) novos compostos farmacêuticos
BRPI0909333A2 (pt) derivado de espiroindolinona
UY33176A (es) Derivados de oxazolopirimidina sustituida en 2, 5, 7.
ECSP109961A (es) Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica
UY29486A1 (es) Compuestos utiles en terapia
CR20110111A (es) Composicion farmaceutica solida

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)